Federal Research Institute of Pediatric Hematology, Oncology and Immunology Report issue

Government Phase 1 Phase 2 Phase 3
Founded: Moscow Russian Federation (1991)

Organization Overview

First Clinical Trial
2008
NCT01953770
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology | Federal Research Center for pediatric hematology, oncology and immunology | Federal Research Institute of Pediatric Hematology, Oncology and Immunology